Clinical Trial

A Study of Transcutaneous Electrical Stimulation As a Noxious Stimulus for the Glasgow Coma Scale

Study acronym: GCS02
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated November 8, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to determine whether electrical stimulation can be used to replace physical stimulation to test awareness of patients with impaired consciousness. Physical stimulation can cause bruising, damaged nails and ribs, and other damage with repeated testing, and electrical stimulation may be safer and cause less distress with time. This device has not been approved by the U.S. Food and Drug Administration (FDA).
Trial Details
NCT Number NCT06681779
Lead Sponsor Markey Olson
Conditions Comatose
Enrollment 90 participants
Start Date 2024-10-31
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-11-08